Discreet and confidential delivery
200,000+ trusted patients
10,305 Reviews on TrustPilot
Excellent
Free online consultation
10,000+ 5* reviews
Wegovy Pills Weight Loss Tablet Containing Semaglutide
10,305 reviews
Wegovy Pills Weight Loss Tablet Containing Semaglutide
Buy Wegovy pills online
Wegovy is currently only available as a once-weekly injection, however, Wegovy pills are currently undergoing UK approval. It is expected that they will be available to the UK market in late 2026.
Summary for Wegovy Pills
| Medication Class | GLP-1 receptor agonist |
|---|---|
| Mechanism of action | Mimics the natural hormone GLP-1 to reduce appetite, increase feelings of fullness, slow gastric emptying, and improve glucose regulation. |
| Active ingredient | Semaglutide |
| Strength | 1.5mg, 4mg, 9mg and 25mg tablets |
| Effective within | Appetite reduction: typically within 1–2 weeks Noticeable weight loss: usually 4–8 weeks, increasing progressively over time Peak clinical effect: 3–6 months and beyond, depending on dose and adherence |
| Dosage instructions | Take one tablet daily |
| Manufacturer | Novo Nordisk |
| Use with alcohol | In moderation |
About Wegovy Pills
Key Points
- There is no approved Wegovy pill in the UK yet. Wegovy is currently injection-only.
- Wegovy oral pills in late-stage trials for weight management.
- Clinical studies show significant weight loss with oral semaglutide, approaching injectable results at higher doses.
- A tablet could offer greater convenience for people who prefer not to use injections.
- Pricing and launch timelines will depend on regulatory approval and manufacturer decisions.
How does the Wegovy pill work?
Wegovy contains semaglutide, a GLP-1 receptor agonist. GLP-1 medicines work by:
- Reducing appetite and increasing feelings of fullness
- Slowing stomach emptying, helping you stay satisfied for longer
- Lowering cravings and caloric intake
- Improving blood-sugar control and insulin sensitivity
An oral (pill) form delivers semaglutide through the digestive system using absorption-enhancing technology so that enough medication enters the bloodstream to produce the same appetite-regulating effects as weight loss injections.
How effective is the Wegovy pill?
Key findings from late-stage studies (e.g., OASIS trials):
- Participants taking oral semaglutide achieved average weight loss of 16.6% of body weight over approximately 68 weeks.
- A third of participants lost 20% or more of their starting weight, within the same trial
- A substantial proportion of patients achieved between 10-5% weight loss, levels associated with meaningful health benefits.
- Appetite reduction and improved portion control were observed early, with progressive weight loss over time.
Bottom line: At higher doses, oral semaglutide produces clinically significant weight loss, although they do not appear to be as effective as weight loss injections.
Wegovy pills vs injections
| Feature | Wegovy Injections | “Wegovy” Pills (Oral Semaglutide) |
|---|---|---|
| Form | Once-weekly injection | Daily tablet |
| Availability | Approved and available in the UK | Not yet approved in the UK |
| Effectiveness | Around 19–21% average weight loss at maintenance doses | Around 17% average weight loss in trials |
| Convenience | Weekly dosing, requires injection | No needles; taken by mouth |
| Onset & consistency | Highly reliable absorption | Absorption can be more variable |
| Side-effect profile | Similar GLP-1 effects (nausea, GI symptoms) | Similar GLP-1 effects |
Summary: Injections remain the gold standard for now. Pills may offer greater convenience but may require strict dosing instructions to ensure reliable absorption.
Are Wegovy pills available in the UK?
No, as of now, there is no approved Wegovy tablet in the UK.
Only the injectable form of Wegovy is licensed for weight management.
Oral semaglutide for obesity is still undergoing regulatory review.
Wegovy pills dosage instructions
| Treatment Phase | Time Period | Dose | Schedule |
|---|---|---|---|
| Starter Dose | Month 1 | 1.5 mg | Once daily |
| Titration 1 | Month 2 | 4 mg | Once daily |
| Titration 2 | Month 3 | 9 mg | Once daily |
| Maintenance | Month 4 onwards | 25 mg | Once daily |
- You begin on a low dose to minimise stomach upset.
- The dose is gradually increased over the first three months. Your prescriber may wish to keep you at one dose for longer than a month to allow your body more time to adjust.
- From month four, you stay on a maintenance dose designed to give the best balance of appetite control and weight loss.
- Tablets would typically be taken once daily, often on an empty stomach with water, to ensure proper absorption.
*Wegovy pills (oral semaglutide for weight management) are not currently licensed or approved in the United Kingdom by the MHRA. The dosing schedule above is based on clinical development and trial protocols and is provided for informational and educational purposes only.
Side effects of Wegovy pills
Side effects are expected to be similar to injectable semaglutide and other GLP-1 medicines:
Common:
- Nausea
- Vomiting
- Diarrhoea or constipation
- Abdominal discomfort
- Reduced appetite
Less common but important:
- Dehydration (secondary to vomiting/diarrhoea)
- Gallbladder issues with rapid weight loss
- Rare pancreatitis
- Most gastrointestinal symptoms are mild to moderate and improve as the body adapts.
Wegovy Pill Warnings
Wegovy pills are not suitable for:
- Individuals with a personal or family history of medullary thyroid carcinoma or MEN2
- An allergy to semaglutide
Caution should be taking in people with:
- Severe gastrointestinal disease
- Type 2 diabetes,
- A history of diabetic retinopathy
- A history of mental health concerns
- An upcoming surgery where sedation is going to be used
Wegovy pill interactions
Potential interactions are expected to mirror injectable semaglutide:
- Diabetes medications (e.g., insulin, sulfonylureas) may increase the risk of low blood sugar.
- Medications requiring rapid absorption may be affected because GLP-1 medicines slow gastric emptying.
Can you use Wegovy pills if you are pregnant or breastfeeding?
- Oral Wegovy pills are not recommended in pregnancy. Weight-loss medicines should be stopped if you are pregnant or planning pregnancy.
- Oral Wegovy pills are not recommended while breastfeeding. There is insufficient safety data regarding exposure to infants.
Frequently Asked Questions
There is no confirmed UK launch date yet, however, a launch in late 2026 is anticipated.
Oral semaglutide for weight management is in advanced development, and availability will depend on regulatory approval by the MHRA and market access decisions.
UK pricing has not been announced. Cost will depend on:
- Final approved dose
- Manufacturer pricing strategy
Not necessarily. In the United States, tablet forms of GLP-1 medicines are usually priced similarly to injections and are often not much cheaper.
If the same happens in the UK, Wegovy pills may cost the same as injections, however, no official pricing has been announced by the manufacturer.
Superintendent Pharmacist
Written by Chemist Click
First created 6th February 2026
Last reviewed 9th February 2026
